Asceneuron, a company in the development of orally bioavailable modulators of tau pathology for the treatment...
Up to date
Appointments
Pharnext Announces the Appointments of Susanne Dorn as Chief Regulatory Officer and Serge Fitoussi as Chief...
Protagen AG, a precision medicine specialist at the forefront of immuno-profiling, announced today the...
Immunocore has appointed Bahija Jallal as Chief Executive Officer and Director of the Board.
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its Board of Directors has named Daniel O’Day...
William Anderson, currently CEO of Genentech, will be appointed CEO Roche Pharmaceuticals effective 1 January...
Share
